Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,715 | -26,953 | -10,862 | -2,690 | N/A |
| Depreciation Amortization | 2 | 2 | 1 | 1 | N/A |
| Other Working Capital | 3,235 | 2,841 | 1,149 | 355 | N/A |
| Other Operating Activity | 352 | 12,686 | 7,187 | 214 | 0 |
| Operating Cash Flow | $-8,127 | $-11,425 | $-2,525 | $-2,120 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | N/A | -4 | N/A |
| Investing Cash Flow | $-2 | $-2 | $N/A | $-4 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,189 | N/A | N/A |
| Debt Repayment | N/A | -105 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 20,100 | 3,274 | 2,635 | N/A |
| Other Financing Activity | 242 | -2,439 | -1,110 | -452 | 0 |
| Financing Cash Flow | $242 | $17,557 | $4,353 | $2,184 | $N/A |
| Exchange Rate Effect | 68 | -19 | -32 | -24 | N/A |
| Beginning Cash Position | 7,943 | 1,832 | 37 | 2 | N/A |
| End Cash Position | 125 | 7,943 | 1,832 | 37 | N/A |
| Net Cash Flow | $-7,818 | $6,111 | $1,795 | $35 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,127 | -11,425 | -2,525 | -2,120 | N/A |
| Capital Expenditure | -2 | -2 | N/A | -4 | N/A |
| Free Cash Flow | -8,128 | -11,427 | -2,525 | -2,125 | 0 |